Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices ...
Graduate students whiz around this slimy beating heart and crawl under the tubes connected to the apparatus cradling the organ as a Medtronic scientist prods a snaking tool around its interior. This ...
What Happened: Disclosed in a Form 4 filing on Tuesday with the U.S. Securities and Exchange Commission, Martha, Chairman and CEO at Medtronic, executed a strategic derivative sale. This involved ...
When you're buying income stocks, a company's underlying business is arguably still the most crucial factor to consider, even ...
Insulin pump therapy, also known as continuous subcutaneous ... including Roche Diagnostics, Sanofi, Abbott, and Medtronic. G.A.F. is President and CEO of Kinexum, which advises multiple health ...
One system consisted of a Stockert SIII roller pump (Sorin Group USA, Arvada, CO) with a Tygon S-95 tubing raceway (Saint-Gobain Performance Plastics, Portage, WI), a Medtronic 0800 or 1500 ...
Medtronic's MiniMed 670G - the closest thing ... the MiniMed 670G insulin pump and an infusion patch. Type 1 diabetes patients using the device will no longer have to self-inject basal insulin ...
Beta Bionics, Inc. (BBNX) is planning to raise $112 million in an initial public offering on Thursday, January 30th, IPO Scoop reports. The company will be issuing 7,500,000 shares at $14.00-$16.00 ...
Beta Bionics (BBNX), a developer of insulin delivery devices, has set terms for an upsized $165M initial public offering. In a recent SEC filing, the company said it was now looking to offer 10M ...
Medtronic's next-gen renal denervation catheter and procedure are in the works to advance the FDA-approved Symplicity Spyral ...
Medical device specialist Medtronic ( MDT 1.05%) has long been a solid dividend stock -- and it has upped its payout for ...
Medtronic is a solid dividend-paying stock. Its stock recently yielded 3.2%. It has increased its payout for nearly 50 years in a row. If you're a dividend investor, I can understand why ...